Τόμος 10 (1992) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 10 (1992) – Issue 3 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

P. KOTRIDES, C. L. PAPADOPOULOS and N. POULANTZAS

10: 145-154 (1992)

PHARMAKON-Press: Epitheorese Klin. Farmakol. Farmakokinet.

10: 145-154 (1992)

Supraventricular tachycardias, mechanisms, treatment

The Supraventricular Tachycar­dias are a result of disordered automaticity, conduction or both. They are classified in: a) sinus nodal, b) atrial tachycardias, c) atrial flutter, and d) atrial fibrillation. The treatment is individ­ualized and taken into consideration the existence of organic cardiac substrate or any other disease. The therapeutic measures range from manipula­tions for vagal stimulations, through several phar­maceutical regimens up to electrical or surgical interventional methods.

1. Narula OS: Sinus node re-entry: a mechanism for supraventricular tachycardia. Circulation 50: 1114 (1974)
2. Wu D et al: Demonstration of sustained sinus and atrial re-entry as a mechanism of paroxysmal supraventricular tachycardia. Circulation, 51:234 (1975)
3. Allessie MΑ and Boke FIM: Reentry within the sinoatrial node as demonstrated by multiple microelectrode rec­ordings in the isolated rabbit heart. In: The Sinus Node: Structure, Function and Clinical Relevance. R.I.M. Bonke (ed.) The Hague, Martinus Nijhoff, 1978.
4. Wellens HJJ: Role of sinus node reentry in the genesis of sustained cardiac arrhythmias. In: See Ref.3, 1978.
5. Gomes JA, Hariman RJ, Kang PS and Chowdry LH: Sustained symptomatic sinus node reentrant tachycar­dia: incidence, clinical significance, electrophysiologic observations απd the effects of antiarrhythmic agents. J. Am. Coll. Cardiol. 5 :45 (1985).